-
2024-12-13 01:45
-
2024-12-12 19:07
ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations, aiming to delay disease progression.The study was presented by theMenarini Group and MEDSIR at th
-
2024-12-11 17:59
-
2024-12-11 10:00
-
2024-12-11 10:00
Early bird discounts now available for a limited time for retail's premier industry event SINGAPORE, Dec. 11, 2024 /PRNewswire/ -- The countdown to the highly anticipated NRF 2025: Retail's Big Show Asia Pacific (NRF 2025 APAC), organised by the National Retail Federation (NRF) i
-
2024-12-10 10:38
-
2024-12-10 09:36
-
2024-12-10 08:47
-
2024-12-09 12:00
-
2024-12-06 12:30